Abstract
Purpose: Corneal cross-linking (CXL) is a relatively new treatment that offers refractive stability in patients with corneal ectatic disorders. The conventional Dresden protocol has been firstly described, and its effectiveness has been demonstrated by several clinical trials. However, the long UVA exposure required, is considered time-consuming and a drawback of the procedure. In order to overcome this issue, the accelerated crosslinking (ACXL) has been lately developed. The purpose of this chapter is to compare the ACXL protocols and the conventional Dresden protocol in terms of visual acuity, keratometric and topographic parameters.
Findings: ACXL protocols seem to be a valid alternative to the conventional protocol; safety and effectiveness of the procedures has been shown by many studies but indirect measurements, such as demarcation line depth, do not always confirm equivalence of protocols. Nevertheless the high fluency procedures offer the advantage of reducing the patient discomfort, achieving a more effective time management, and avoiding the excessive corneal dehydration and thinning.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Remé C, Reinboth J, Clausen M, Hafezi F. Light damage revisited: converging evidence, diverging views? Graefes Arch Clin Exp Ophthalmol. 1996;234(1):2–11.
Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135:620–7.
Hafezi F, Kanellopoulos J, Wiltfang R, Seiler T. Corneal collagen crosslinking with riboflavin and ultraviolet A to treat induced keratectasia after laser in situ keratomileusis. J Cataract Refract Surg. 2007;33(12):2035–40.
Caporossi A, Mazzotta C, Baiocchi S. Long-term results of riboflavin ultraviolet a corneal collagen cross-linking for keratoconus in Italy: the Siena Eye Cross Study. Am J Ophthalmol. 2010;149(4):585–93.
Vinciguerra P, Albe E, Trazza S. Intraoperative and postoperative effects of corneal collagen cross-linking on progressive keratoconus. Arch Ophthalmol. 2009;127(10):1258–65.
Spoerl E, Mrochen M, Sliney D, Trokel S, Seiler T. Safety of UVAriboflavin cross-linking of the cornea. Cornea. 2007;26(4):385–9.
Kymionis GD, Kontadakis GA, Hashemi KK. Accelerated versus conventional corneal crosslinking for refractive instability: an update. Curr Opin Ophthalmol. 2017;28(4):343–7.
Randleman JB, Khandelwal SS, Hafezi F. Corneal cross-linking. Surv Ophthalmol. 2015;60(6):509–23.
Bunsen RW, Roscoe HE. Photochemical researches – part V. On the measurement of the chemical action of direct and diffuse sunlight. Proc R Soc Lond. 1862;12:306–12.
Shetty R, Pahuja NK, Nuijts RM, et al. Current protocols of corneal collagen cross-linking: visual, refractive, and tomographic outcomes. Am J Ophthalmol. 2015;160:243–9.
Wernli J, Schumacher S, Spoerl E, Mrochen M. The efficacy of corneal cross-linking shows a sudden decrease with very high intensity UV light and short treatment time. Invest Ophthalmol Vis Sci. 2013;54:1176–80.
Akkaya TS, Toker E. Changes in corneal density after accelerated corneal collagen cross-linking with different irradiation intensities and energy exposures: 1-year follow-up. Cornea. 2017;36(11):1331–5.
Kanellopoulos AJ. Long term results of a prospective randomized bilateral eye comparison trial of higher fluence, shorter duration ultraviolet A radiation, and riboflavin collagen cross linking for progressive keratoconus. Clin Ophthalmol. 2012;6:97–101.
Elbaz U, Shen C, Lichtinger A, et al. Accelerated (9-mW/cm2) corneal collagen crosslinking for keratoconus-A 1-year follow-up. Cornea. 2014;33:769–73.
Cınar Y, Cingü AK, Türkcü FM, et al. Comparison of accelerated and conventional corneal collagen cross-linking for progressive keratoconus. Cutan Ocul Toxicol. 2014;33:218–22.
Kymionis GD, Grentzelos MA, Kankariya VP, et al. Safety of high-intensity corneal collagen crosslinking. J Cataract Refract Surg. 2014;40:1337–40.
Ulusoy DM, Göktaş E, Duru N, et al. Accelerated corneal crosslinking for treatment of progressive keratoconus in pediatric patients. Eur J Ophthalmol. 2017;27:319–25.
Sachdev GS, Sachdev M. Recent advances in corneal collagen cross-linking. Indian J Ophthalmol. 2017;65:787–96.
Richoz O, Hammer A, Tabibian D, et al. The biomechanical effect of corneal collagen crosslinking (CXL) with riboflavin and UV-A is oxygen dependent. Transl Vis Sci Technol. 2013;2:6.
Mazzotta C, Traversi C, Paradiso AL, Latronico ME, Rechichi M. Pulsed light accelerated crosslinking versus continuous light accelerated crosslinking: one-year results. J Ophthalmol. 2014;2014:604731.
Spadea L, Tonti E, Vingolo EM. Corneal stromal demarcation line after collagen cross-linking in corneal ectatic diseases: a review of the literature. Clin Ophthalmol. 2016;10:1803–10.
Moramarco A, Iovieno A, Sartori A, Fontana L. Corneal stromal demarcation line after accelerated crosslinking using continuous and pulsed light. J Cataract Refract Surg. 2015;41(11):2546–51.
Akbar B, Intisar-Ul-Haq R, Ishaq M, Arzoo S, Siddique K. Transepithelial corneal crosslinking in treatment of progressive keratoconus: 12 months’ clinical results. Pak J Med Sci. 2017;33(3):570–5.
Magli A, Chiariello Vecchio E, Carelli R, Piozzi E, Di Landro F, Troisi S. Pediatric keratoconus and iontophoretic corneal crosslinking: refractive and topographic evidence in patients underwent general and topical anesthesia, 18 months of follow-up. Int Ophthalmol. 2016;36(4):585–90.
Kanellopoulos AJ. Collagen cross-linking in early keratoconus with riboflavin in a femtosecond laser-created pocket: initial clinical results. J Refract Surg. 2009;25(11):1034–7.
Wollensak G, Iomdina E. Biomechanical and histological changes after corneal crosslinking with and without epithelial debridement. J Cataract Refract Surg. 2009;35(3):540–6.
Bikbova G, Bikbov M. Transepithelial corneal collagen cross-linking by iontophoresis of riboflavin. Acta Ophthalmol. 2014;92(1):e30–4.
Spadea L, Maraone G, Cagini C. Sliding keratoplasty followed by transepithelial iontophoresis collagen cross-linking for pellucid marginal degeneration. J Refract Surg. 2016;31(19):47–50.
Bikbova G, Bikbov M. Standard corneal collagen crosslinking versus transepithelial iontophoresis-assisted corneal crosslinking, 24 months follow-up: randomized control trial. Acta Ophthalmol. 2016;94(7):e600–6.
Cummings AB, McQuaid R, Naughton S, Brennan E, Mrochen M. Optimizing corneal cross-linking in the treatment of keratoconus: a comparison of outcomes after standard- and high-intensity protocols. Cornea. 2016;35(6):814–22.
Sadoughi MM, Einollahi B, Baradaran-Rafii A, et al. Accelerated versus conventional corneal collagen cross-linking in patients with keratoconus: an intrapatient comparative study. Int Ophthalmol. 2018;38:67–74.
Kymionis GD, Tsoulnaras KI, Grentzelos MA, et al. Corneal stroma demarcation line after standard and high intensity collagen crosslinking determined with anterior segment optical coherence tomography. J Cataract Refract Surg. 2014;40:736–40.
Ng AL, Chan TC, Lai JS, Cheng AC. Comparison of the central and peripheral corneal stromal demarcation line depth in conventional versus accelerated collagen cross-linking. Cornea. 2015;34(11):1432–6.
Kymionis GD, Tsoulnaras KI, Grentzelos MA, et al. Evaluation of corneal stromal demarcation line depth following standard and a modified-accelerated collagen cross-linking protocol. Am J Ophthalmol. 2014;158:671–675.e1.
Chow VW, Chan TC, Yu M, Wong VW, Jhanji V. One-year outcomes of conventional and accelerated collagen crosslinking in progressive keratoconus. Sci Rep. 2015;5:14425.
Hashemi H, Miraftab M, Seyedian MA, et al. Long-term results of an accelerated corneal cross-linking protocol (18 mW/cm2) for the treatment of progressive keratoconus. Am J Ophthalmol. 2015;160(6):1164–70.
Hashemi H, Fotouhi A, Miraftab M, et al. Short-term comparison of accelerated and standard methods of corneal collagen crosslinking. J Cataract Refract Surg. 2015;41:533–40.
Tomita M, Mita M, Huseynova T. Accelerated versus conventional corneal collagen crosslinking. J Cataract Refract Surg. 2014;40:1013–20.
Hashemian H, Jabbarvand M, Khodaparast M, Ameli K. Evaluation of corneal changes after conventional versus accelerated corneal cross-linking: a randomized controlled trial. J Refract Surg. 2014;30(12):837–42.
Ozgurhan EB, Celik U, Bozkurt E, Demirok A. Evaluation of subbasal nerve morphology and corneal sensation after accelerated corneal collagen cross-linking treatment on keratoconus. Curr Eye Res. 2015;40(5):484–9.
Cingu AK, Sogutlu-Sari E, Cınar Y, et al. Transient corneal endothelial changes following accelerated collagen cross-linking for the treatment of progressive keratoconus. Cutan Ocul Toxicol. 2014;33:127–31.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Spadea, L., Napolitano, R., Tonti, E., De Rosa, V. (2019). Accelerated Corneal Cross-Linking. In: Barbara, A. (eds) Controversies in the Management of Keratoconus . Springer, Cham. https://doi.org/10.1007/978-3-319-98032-4_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-98032-4_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-98031-7
Online ISBN: 978-3-319-98032-4
eBook Packages: MedicineMedicine (R0)